000 05104nam a22006375i 4500
001 978-3-031-65827-3
003 DE-He213
005 20250516160106.0
007 cr nn 008mamaa
008 240720s2024 sz | s |||| 0|eng d
020 _a9783031658273
_9978-3-031-65827-3
050 4 _aRC261-271
072 7 _aMJCL
_2bicssc
072 7 _aMED062000
_2bisacsh
072 7 _aMJCL
_2thema
082 0 4 _a571.978
_223
082 0 4 _a616.994
_223
245 1 0 _aBreast Cancer Treatment: An Interdisciplinary Approach
_h[electronic resource] /
_cedited by Nima Rezaei.
250 _a1st ed. 2024.
264 1 _aCham :
_bSpringer Nature Switzerland :
_bImprint: Springer,
_c2024.
300 _aXI, 448 p. 54 illus., 50 illus. in color.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
490 1 _aInterdisciplinary Cancer Research,
_x2731-457X ;
_v7
505 0 _aSignal Transducer and Activator of Transcription as a Potential Therapeutic Target in Breast Cancer -- Triple-Negative Breast Cancer Therapy: Recent Advances, Challenges, and Future Perspective -- Advances in Local Ablative Techniques for Breast Cancer -- Radiotherapy in Breast Cancer -- Percutaneous Breast Cancer Treatment -- Revolutionizing Breast Cancer Care: Cutting-Edge Breakthroughs and Future Frontiers in Precision Medicine -- Updates on the Management of Ductal Carcinoma In Situ of the Breasts -- Nanostructured Lipid Carrier as a Strategy for the Treatment of Breast Cancer -- Managing Breast Cancer Using the Cell-Surface GRP78 -- A Hormone Immunotherapy (HIT) Combination in Advanced Breast Cancer -- Discovering New Targets in Triple-Negative Breast Cancer (TNBC): The Androgen Receptor and the Estrogen Receptor b -- Growth Factor Receptor Implications in Breast Cancer: Prospects for Their Molecular Transactivation in the Future and Obstacles for Target Therapy -- Addressing ESR1 Mutation: A Key Factor in Hormone Therapy Resistance in Breast Cancer -- Tumor Microenvironment Modulation and Its Impact on Immunotherapy in Triple-Negative Breast Cancer -- Claudin 1: An Emerging Target for Triple-Negative Breast Cancer -- Histaminergic System as a Promising Target for Breast Cancer Treatment -- Nutrient Transporters: New Molecular Targets for Triple Negative Breast Cancer in Type 2 Diabetics -- Holistic Nursing Approach: A Case Study on Integrating Traditional Chinese Medicine into Nursing Care for a Patient with Upper Limb Lymphedema and Coexisting Pressure Injury Post-breast Cancer Surgery.
520 _aThere are different types of treatment for breast cancer, including surgery, chemotherapy, radiotherapy, hormone therapy, immunotherapy, and targeted therapy. Deciding on the types of treatment depends on several factors, such as the stage and grade of cancer, biomarkers, and general health of patients. The seventh volume of the "Interdisciplinary Cancer Research" series, entitled "Breast Cancer Treatment: An Interdisciplinary Approach" publishes comprehensive reviews on different treatment opportunities on breast cancer. An update on treatment of triple-negative breast cancer and ductal carcinoma in situ is provided. Ablative breast cancer surgery, radiotherapy, and percutaneous breast cancer treatment are explained. Promising hormone immunotherapy combination as well as targeted therapies for breast cancer is also discussed. This interdisciplinary series is of special value to researchers working on oncology. This is the main concept of Cancer Immunology Project (CIP), which is a part of Universal Scientific Education and Research Network (USERN). This interdisciplinary book will be of special value to researchers and oncologists who wish to extend their knowledge on breast cancer treatment.
541 _fUABC ;
_cPerpetuidad
650 0 _aCancer.
650 0 _aCancer
_xTreatment.
650 0 _aNanomedicine.
650 0 _aTumors
_xImmunological aspects.
650 0 _aImmunology.
650 0 _aOncology.
650 1 4 _aCancer Biology.
650 2 4 _aCancer Therapy.
650 2 4 _aCancer Nanotechnology.
650 2 4 _aTumour Immunology.
650 2 4 _aApplied Immunology.
650 2 4 _aOncology.
700 1 _aRezaei, Nima.
_eeditor.
_0(orcid)0000-0002-3836-1827
_1https://orcid.org/0000-0002-3836-1827
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
710 2 _aSpringerLink (Online service)
773 0 _tSpringer Nature eBook
776 0 8 _iPrinted edition:
_z9783031658266
776 0 8 _iPrinted edition:
_z9783031658280
776 0 8 _iPrinted edition:
_z9783031658297
830 0 _aInterdisciplinary Cancer Research,
_x2731-457X ;
_v7
856 4 0 _zLibro electrónico
_uhttp://libcon.rec.uabc.mx:2048/login?url=https://doi.org/10.1007/978-3-031-65827-3
912 _aZDB-2-SBL
912 _aZDB-2-SXB
942 _cLIBRO_ELEC
999 _c275727
_d275726